A detailed history of Handelsinvest Investeringsforvaltning transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 1,518 shares of CRL stock, worth $285,232. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,518
Previous 2,306 34.17%
Holding current value
$285,232
Previous $545,000 24.59%
% of portfolio
0.2%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$203.52 - $273.43 $160,373 - $215,462
-788 Reduced 34.17%
1,518 $411,000
Q4 2023

Jan 11, 2024

SELL
$164.52 - $238.84 $2.91 Million - $4.23 Million
-17,694 Reduced 88.47%
2,306 $545,000
Q3 2023

Oct 26, 2023

BUY
$194.44 - $217.61 $3.89 Million - $4.35 Million
20,000 New
20,000 $3.92 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.